Quincy Bioscience’s Prevagen
May 2020: The parties moved to stay this case pending approval of a nationwide class settlement. The terms of the settlement have not been disclosed.
July 2019: A class-action lawsuit was filed against Quincy Bioscience for allegedly falsely advertising that the dietary supplement Prevagen improves memory within 90 days and supports “Healthy Brain Function,” “Sharper Mind,” and “Clearer Thinking” when, according to plaintiffs, the supplement does not provide the advertised benefits. (Plaintiffs filed an amended complaint bringing similar allegations in September 2019.) (Collins et al v. Quincy Bioscience, LLC, Case No. 19-cv-22864, S. D. FL.)
For more of TINA.org’s coverage of Prevagen, click here.